<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>20</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>LINC01204 Negatively Regulates the Effect of MiR-214 on Lung Cancer Cell Apoptosis, Migration, Invasion and Radio-sensitivity</title>
	<subject_fa>Radiobiology</subject_fa>
	<subject>Radiobiology</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;Background: To investigate whether LncRNA LINC01204 affects lung cancer cell apoptosis, migration, invasion and radiosensitivity by regulating miR-214. Materials and Methods: Normal lung cells HBE and lung cancer cells A549 were cultured in-vitro, and pcDNA3.1, pcDNA3.1-LINC01204, pcDNA3.1-LINC01204 and miR-NC, pcDNA3.1-LINC01204 and miR-214 mimics were transfected into A549 cells, respectively. qRT-PCR, flow cytometry, scratch test, and Transwell chamber test, clone formation test, dual luciferase, and Western blot methods were used in this study. Results: Compared with HBE cells, A549 cells had significantly reduced LINC01204 expression level (P&lt;0.05), and significantly increased miR-214 expression level (P&lt;0.05); transfection of pcDNA3.1-LINC01204 could significantly increase apoptosis rate and Cleaved-caspase3, E-cadherin protein levels (P&lt;0.05), reduce migration healing rate, N-cadherin protein levels and cell survival fraction (P&lt;0.05) with sensitization enhancement ratio SER at 1.950, reduce the number of invasive cells (P&lt;0.05). Dual luciferase report experiments confirmed that LINC01204 can bind to miR-214 in a targeted way; co-transfection of pcDNA3.1-LINC01204 and miR-214 mimics can significantly reduce the apoptosis rate and Cleaved-caspase3 and E-cadherin protein levels (P&lt;0.05), improve the migration healing rate, N-cadherin protein level and cell survival fraction (P&lt;0.05) with sensitization enhancement ratio SER at 0.728, increase the number of invasive cells (P&lt;0.05). Conclusion: LINC01204 overexpression can negatively regulate miR-214 expression to promote lung cancer cell apoptosis and inhibit migration and invasion, thereby enhancing radiosensitivity.&lt;/div&gt;
&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>LncRNA LINC01204, miR-214, lung cancer, apoptosis, migration, invasion, radiosensitivity.</keyword>
	<start_page>15</start_page>
	<end_page>20</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-2188-55&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>X.N. </first_name>
	<middle_name></middle_name>
	<last_name>Yu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460020690</code>
	<orcid>7900319475328460020690</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Oncology, Weihai Central Hospital, Weihai, 264400, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>M. </first_name>
	<middle_name></middle_name>
	<last_name>Wang</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>wangming99801@163.com </email>
	<code>7900319475328460020691</code>
	<orcid>7900319475328460020691</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Oncology, Weihai Central Hospital, Weihai, 264400, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
